Literature DB >> 9727962

Correlates of functional status in older patients with schizophrenia.

T L Patterson1, J C Klapow, J H Eastham, R K Heaton, J D Evans, W L Koch, D V Jeste.   

Abstract

There is a growing recognition of the importance of quantifying the impact of illness on functional abilities. Measures of function frequently rely on a self-report. Few studies have directly assessed functional capacity in psychiatric patients, especially older ones who may be at an increased risk for disability. Subjects were 102 middle-aged and elderly outpatients with DSM-III-R or DSM-IV diagnosis of schizophrenia or schizoaffective disorder, and 66 normal comparison subjects, ranging in age from 45 to 86. The Direct Assessment of Functional Status (DAFS), a standardized measure of behavior during simulated daily activity tasks (i.e. time orientation, communication, transportation, finance, shopping, grooming and eating) was used to quantify levels of disability. Schizophrenic patients demonstrated significantly greater disability than normal subjects. An evaluation of specific behaviors indicated that the patients were significantly more limited than comparison subjects across all subscales of the DAFS except for grooming and eating. A lower level of formal education, greater severity of extrapyramidal symptoms, and greater cognitive deficits, but not severity of symptoms of schizophrenia, were related to lower DAFS scores. Relative to published findings, schizophrenic patients appeared more disabled than outpatients with major depression, but less disabled than those with Alzheimer's disease. The DAFS is a useful instrument for characterizing functional abilities in older patients with schizophrenia. Our findings of significant functional disability in older schizophrenic patients have implications for treatment as well as allocation of health-care resources.

Entities:  

Mesh:

Year:  1998        PMID: 9727962     DOI: 10.1016/s0165-1781(98)00060-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Exploratory analysis of normative performance on the UCSD Performance-Based Skills Assessment-Brief.

Authors:  Lea Vella; Thomas L Patterson; Philip D Harvey; Margaret McNamara McClure; Brent T Mausbach; Michael J Taylor; Elizabeth W Twamley
Journal:  Psychiatry Res       Date:  2017-06-12       Impact factor: 3.222

Review 2.  Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

3.  Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine.

Authors:  Simon Zhornitsky; Emmanuel Stip; Joelle Desfossés; Tania Pampoulova; Elie Rizkallah; Pierre-Paul Rompré; Lahcen Aït Bentaleb; Olivier Lipp; Jean-Pierre Chiasson; Alain Gendron; Stéphane Potvin
Journal:  Front Psychiatry       Date:  2011-05-13       Impact factor: 4.157

4.  Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness.

Authors:  Kim T Mueser; Sarah I Pratt; Stephen J Bartels; Karin Swain; Brent Forester; Corinne Cather; James Feldman
Journal:  J Consult Clin Psychol       Date:  2010-08

Review 5.  New wine in old bottle: late-life psychosis.

Authors:  Alana Iglewicz; Thomas W Meeks; Dilip V Jeste
Journal:  Psychiatr Clin North Am       Date:  2011-06

6.  Functioning in middle aged and older patients with schizophrenia and depressive symptoms: relationship to psychopathology.

Authors:  John Kasckow; Thomas Patterson; Ian Fellows; Shahrokh Golshan; Ellen Solorzano; Somaia Mohamed; Sidney Zisook
Journal:  Am J Geriatr Psychiatry       Date:  2008-08       Impact factor: 4.105

Review 7.  Aripiprazole for late-life schizophrenia.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

8.  Multivariate predictors of social skills performance in middle-aged and older out-patients with schizophrenia spectrum disorders.

Authors:  D I Sitzer; E W Twamley; T L Patterson; D V Jeste
Journal:  Psychol Med       Date:  2007-09-06       Impact factor: 7.723

9.  Cognitive performance of individuals with schizophrenia across seven decades: a study using the MATRICS consensus cognitive battery.

Authors:  Tarek K Rajji; Aristotle N Voineskos; Meryl A Butters; Dielle Miranda; Tamara Arenovich; Mahesh Menon; Zahinoor Ismail; Robert S Kern; Benoit H Mulsant
Journal:  Am J Geriatr Psychiatry       Date:  2013-01-22       Impact factor: 4.105

10.  The impact of aging, cognition, and symptoms on functional competence in individuals with schizophrenia across the lifespan.

Authors:  Sawsan M Kalache; Benoit H Mulsant; Simon J C Davies; Angela Y Liu; Aristotle N Voineskos; Meryl A Butters; Dielle Miranda; Mahesh Menon; Robert S Kern; Tarek K Rajji
Journal:  Schizophr Bull       Date:  2014-08-06       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.